Gateway Pharmacy and Sarhaddi Pharmaceutical Inc. are aware of fraudulent emails and websites falsely offering employment opportunities in our name.
We never request payment from applicants. If you receive suspicious communications claiming to represent our company, please contact us directly to verify authenticity.
Next-Generation Blood Test Improves Detection of Aggressive Prostate Cancer
A study of more than 12,600 men found the Stockholm3 blood test detected significantly more aggressive prostate cancers than the standard PSA test, without increasing unnecessary follow-up testing.
Health News is provided as a service to Gateway Pharmacy site users by HealthDay. Gateway Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.